Provider

Preimplantation Genetic Testing for Human Leukocyte Antigens (PGT-HLA) provides patients with an option not only to avoid an inherited risk when combined with single gene testing (PGT-M), but also to establish a pregnancy with an exact HLA match to benefit an affected family member.

RGI recommends Preimplantation Genetic Testing for aneuploidy (PGT-A). Biopsy of a 5-6 day blastocyst can be performed before or after cryopreservation . PGT-A will reveal the chromosomal status of each embryo, allowing a single euploid embryo to be selected.

If you or your partner have a family history of heart attack or sudden death at a young age, family members with pacemakers or internal cardiac defibrillators, arrhythmia, and cardiac surgery you may consider carrier screening. Carrier Screening will determine whether PGT should be considered as is an option during your family planning. With Preimplantation Genetic Testing (PGT), there is a way to prevent your children from being carriers of the same gene mutation.